semaglutide spleen Should a 17-year-old patient with spleenomegaly continue taking Wegovy ( semaglutide)? Evaluation of gastric content in

Evidence from pivotal trials, such as the EMPA-REG OUTCOME (Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients-Removing Excess Glucose) and CANVAS (Canagliflozin Cardiovascular Assessment Study) studies, underscores the kidney benefits of SGLT2is, highlighting significant reductions in the progression of kidney disease and CV mortality[70,71]

Thousands have already experienced the benefits of semaglutide for weight loss and now, its your turn

If left untreated, it can have serious practical consequences

Patients who inadvertently leave semaglutide unrefrigerated beyond the recommended timeframes or expose an in-use pen to excessive heat may not experience obvious immediate consequences, which can create a false sense of security

Both are highly effective weight loss drugs